Europe Pharmaceutical Robots Market to Grow at a CAGR of 13.0% to reach US$ 95.30 million from 2021 to 2028

Europe Pharmaceutical Robots Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Collaborative Pharmaceutical Robots and Traditional Robots), Application (Inspection of Pharmaceutical Drugs, Laboratory Applications, and Picking and Packaging), and End User (Pharmaceutical Companies, Research Laboratories, and Contract Research Organizations)

  • Report Code : TIPRE00025566
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 135
Buy Now

The Europe pharmaceutical robots market is expected to grow from US$ 40.45 million in 2021 to US$ 95.30 million by 2028; it is estimated to grow at a CAGR of 13.0% from 2021 to 2028.



Pharmaceutical and biotechnology companies focus on research and development (R&D) to develop new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest large amounts in R&Ds to deliver high-quality and innovative products to the market. Drug development and discovery are time-consuming and expensive processes. However, pharmaceutical robots help pharmaceutical companies reduce costs and increase efficiency in the drug discovery process. Many repetitive tasks, such as moving fluids and test tubes, are performed in the research and development of drugs. In such a scenario, robots are used to automate the process as they offer a high level of accuracy and consistency. As a result, scientists can avoid menial tasks and focus on more meaningful activities, such as drug development research. Therefore, the increasing expenditure on research and development in pharmaceutical and biotechnology companies to save cost and time and to improve the drug discovery process propels the growth of the pharmaceutical robots market
 

As the coronavirus cases increase in the area, many countries are fighting to control the disease's spread. Artificial intelligence (AI) and machine learning represent a crucial part in better knowing and discussing the COVID-19 crisis. Machine learning technology permits computers to mimic human intelligence and ingest large volumes of data to identify patterns and insights quickly. In the fight toward COVID-19, associations have been instantaneous to utilize their machine learning expertise in several areas, such as scaling customer connections and knowing COVID-19 spreads and speeds up research and medication. The researchers recorded an elevated selection and use of AI in scientific and medical research, particularly in applications such as medical diagnosis, telemedicine, epidemiological studies, and clinical management of patients. There was also a shift in approaches towards AI and data distribution. According to the study, the crisis occurred in a comprehensive agreement of robots in the workplace and data distribution to monitor the virus's spread. In March 2020, Robotiq launched a pandemic initiative called Cobots vs. COVID. The program aims to help essential goods manufacturers such as medical equipment, pharmaceuticals, and others, rapidly increase their production by deploying cobot cells.  Such initiatives in the region open a window of opportunities for the market players involved in the pharmaceutical robots market.
 

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe pharmaceutical robots market. Several conferences, workshops, and exhibitions are being held across the region to spread the awareness of robotic systems. For instance, GlaxoSmithKline, has collaborated with other pharmaceutical companies to assess the robotic platforms for precise, automated dispensing of solids and AstraZeneca has worked on combined efforts to improve the measurement and prediction of active pharmaceutical ingredient (API) solubility. Also, the Digital Robot Pharma Fab Workshop was held in June 2019 in Amsterdam, The Netherlands. The workshop demonstrated the applications of robotics in the pharmaceutical industry and introduced the advantages and risks associated with it. The workshop included lectures and hands-on training by mock-ups and live activities presented in the exhibition hall. Moreover, on April 20–21, 2021, Scientific Program Planning Committee and Parenteral Drug Association (PDA) Europe held PDA Robotics and Automation Conference, a virtual event. Its theme was “Challenges and Opportunities of Robotics and Automation—A Paradigm Shift within the Pharma Industry”. Thus, the growing conferences, workshops, and exhibitions to create awareness regarding pharmaceutical robots propel the growth of the pharmaceutical robots market in Europe.
 
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Europe Pharmaceutical Robots Market Segmentation

  • Europe Pharmaceutical Robots Market – By Product
    • Collaborative Pharmaceutical Robots
    • Traditional Robots
  • Europe Pharmaceutical Robots Market – By Application
    • Inspection of Pharmaceutical Drugs
    • Laboratory Applications
    • Picking and Packaging
  • Europe Pharmaceutical Robots Market – By End User
    • Pharmaceutical Companies
    • Research Laboratories
    • Contract Research Organizations
  • Europe Pharmaceutical Robots Market – By Country
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  1. ABB
  2. Kawasaki Heavy Industries, Ltd.
  3. YASKAWA ELECTRIC CORPORATION
  4. Universal Robots
  5. Marchesini Group S.p.A
  6. DENSO Corporation
  7. FANUC CORPORATION
  8. Seiko Epson Corporation
  9. WEISS GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Pharmaceutical Robots Market